7 October 2013 - Newcastle: Aesica, the global contract development and manufacturing organisation (CDMO), has extended its aseptic capabilities at its Nottingham site with the acquisition of new ...

SAN DIEGO, March 30, 2017 /PRNewswire/ -- Pre-Filled Syringes West Coast will gather some of the industry's most leading names in medical devices to cover key topics in regulation and strategy; ...

WUXI, China, June 5, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global CRDMO service company, announced it has successfully launched the GMP operation of its new drug product ...

LONDON--(BUSINESS WIRE)--Technavio has announced the top five leading vendors in their recent global pre-filled syringes market 2017-2021 report. This market research report also lists nine other ...

LONDON--(BUSINESS WIRE)--The global pre-filled syringes market size is expected to grow by USD 4.23 billion as per Technavio. This marks a significant market growth compared to the 2019 growth ...

WuXi Biologics, a CDMO, launched the GMP operation of its new drug product facility DP5 located in Wuxi, China. The DP5 is the ninth operational drug product facility in the global network of WuXi ...

NEW YORK, June 8, 2020 /PRNewswire/ -- The Global Pre Filled Syringes Market is expected to grow from USD 4,215.13 Million in 2018 to USD 6,845.13 Million by the end of 2025 at a Compound Annual ...

Dublin, Sept. 18, 2025 (GLOBE NEWSWIRE) -- The "Pre-Filled Syringes Market, Type, Material, Design, Delivery, and Application - Global Market Size, Segmental Analysis, Regional Overview, Company ...

The US Food and Drug Administration (FDA) has rejected a prefilled syringe version of Regeneron's ophthalmology blockbuster Eylea HD (aflibercept), as manufacturing shortcomings continue to plague the ...